iX Biopharma Ltd.'s market cap is currently ―. The company's EPS TTM is S$-0.012; its P/E ratio is -3.28; iX Biopharma Ltd. is scheduled to report earnings on August 19, 2024, and the estimated EPS forecast is S$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 21	Dec 20	Dec 19	Sep 19	Jun 19
Income Statement	-
Total Revenue	-	-	S$ 174.00K	S$ 120.00K	S$ 129.00K
Gross Profit	-	-	S$ -160.00K	S$ -235.00K	S$ -214.00K
EBIT	-	-	S$ -2.36M	S$ -3.28M	S$ -3.42M
EBITDA	-	-	S$ -2.10M	S$ -3.02M	S$ -3.25M
Net Income Common Stockholders	-	-	S$ -2.42M	S$ -3.35M	S$ -3.77M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	S$ 6.21M	S$ 10.09M	S$ 10.78M	S$ 13.72M	S$ 15.87M
Total Assets	S$ 18.86M	S$ 23.41M	S$ 21.29M	S$ 24.03M	S$ 26.69M
Total Debt	S$ 4.24M	S$ 4.55M	S$ 4.12M	S$ 4.22M	S$ 3.83M
Net Debt	S$ -1.97M	S$ -5.53M	S$ -6.66M	S$ -9.51M	S$ -12.04M
Total Liabilities	S$ 7.15M	S$ 6.97M	S$ 6.18M	S$ 6.41M	S$ 6.19M
Stockholders Equity	S$ 11.71M	S$ 16.45M	S$ 15.12M	S$ 17.62M	S$ 20.50M
Cash Flow	-
Free Cash Flow	-	-	S$ -2.75M	S$ -1.88M	S$ -2.11M
Operating Cash Flow	-	-	S$ -2.52M	S$ -1.70M	S$ -1.91M
Investing Cash Flow	-	-	S$ -227.00K	S$ -181.00K	S$ 443.00K
Financing Cash Flow	-	-	S$ -199.00K	S$ -201.00K	S$ -1.26M

Currency in SGD

iX Biopharma Ltd. Earnings and Revenue History

Income Statement >

iX Biopharma Ltd. Debt to Assets

Balance Sheet >

iX Biopharma Ltd. Cash Flow

Cash Flow >

iX Biopharma Ltd. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing